Despite these promising developments and an accelerated development of many FAP-targeted radiotracers, only little therapeutic benefit has been demonstrated with FAP-TRT to date, mainly due to suboptimal tumor retention [6, 10], and future studies are needed to determine the anti-cancer potential of FAP-TRT. Here, FAP is linked to neoplasm.